The Neuropeptide Signalling Set groups Semax, Selank, BPC-157, NAD+ and Pinealon for cell based and ex vivo models of neurotransmission, neurotrophic support and synaptic plasticity. It is the broadest of the neuroscience sets in the NuVion range.
Neuropeptide signalling research set
A combination of neuroactive peptides used in cell based and ex vivo models of neurotransmission, neurotrophic support and synaptic plasticity.
Research profiles: Semax, Selank, BPC-157, NAD+ and Pinealon
What is tested in this set
This set contains five products, each supplied in its own vial and each tested on its own. The table lists the published result for every component.
| Component | Purity | Laboratory | Analysed | Certificate |
|---|---|---|---|---|
| Semax | 99.57% | Janoshik Analytical | 5 Feb 2026 | View |
| Selank | 99.89% | Janoshik Analytical | 10 Apr 2026 | View |
| BPC-157 | 99.93% | Janoshik Analytical | 24 Sep 2026 | View |
| NAD+ | 99.84% | Janoshik Analytical | 17 Oct 2025 | View |
| Pinealon | 99.39% | Janoshik Analytical | 23 Apr 2026 | View |










